The role of ibrutinib in COVID-19 hyperinflammation: A case report

The role of ibrutinib in COVID-19 hyperinflammation: A case report

Immune modulation in COVID-19 is emerging as an important therapeutic strategy as increasing evidence suggests that inflammatory pathways are implicated in lung damage. Bruton tyrosine kinase inhibitors (BTKi), such as ibrutinib, are commonly used to treat indolent B-cell neoplasms and chronic graft...

Full description

Bibliographic Details
Main Authors: Suzanne Maynard, Jose Ros-Soto, Aris Chaidos, Andrew Innes, Krushika Paleja, Eitan Mirvis, Noora Buti, Harriet Sharp, Renuka Palanicawandar, Dragana Milojkovic
Format: Article
Language:English
Published: Elsevier 2021-04-01
Series:International Journal of Infectious Diseases
Subjects:
COVID-19
BTK-inhibitor
Ibrutinib
Waldenstrom macroglobulinaemia
Online Access:http://www.sciencedirect.com/science/article/pii/S1201971221001429

Internet

http://www.sciencedirect.com/science/article/pii/S1201971221001429

Similar Items